NPI: 1477532174 · MARSHALLTOWN, IA 50158 · 152WC0802X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,860 | $1.75M |
| 2019 | 19,903 | $2.85M |
| 2020 | 17,977 | $2.95M |
| 2021 | 21,438 | $2.91M |
| 2022 | 25,040 | $2.68M |
| 2023 | 25,347 | $2.95M |
| 2024 | 19,734 | $2.14M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J0178 | Aflibercept injection | 11,295 | 7,599 | $8.03M |
| 67028 | 28,880 | 24,330 | $3.76M | |
| J2778 | Ranibizumab injection | 2,732 | 2,016 | $1.66M |
| J2777 | Inj, faricimab-svoa, 0.1mg | 1,288 | 774 | $988K |
| 92134 | 34,124 | 29,342 | $663K | |
| 99213 | 17,356 | 16,144 | $594K | |
| 99214 | 11,190 | 10,159 | $474K | |
| J3590 | Unclassified biologics | 5,857 | 3,704 | $412K |
| 99204 | 4,307 | 4,108 | $397K | |
| 66984 | 1,307 | 854 | $293K | |
| 99203 | 2,736 | 2,580 | $192K | |
| 92060 | 3,498 | 3,340 | $153K | |
| 92014 | 2,799 | 2,515 | $96K | |
| 92201 | 2,262 | 1,074 | $69K | |
| J9035 | Bevacizumab injection | 1,912 | 1,214 | $64K |
| 99222 | 670 | 623 | $61K | |
| 99232 | 1,274 | 597 | $56K | |
| 92015 | 4,121 | 3,919 | $53K | |
| 92250 | 1,529 | 1,319 | $41K | |
| 92004 | 392 | 368 | $30K | |
| 92136 | 1,074 | 454 | $28K | |
| 92083 | 992 | 907 | $28K | |
| 92133 | 1,039 | 953 | $24K | |
| 92226 | 668 | 152 | $20K | |
| 67311 | 45 | 37 | $19K | |
| 92012 | 344 | 334 | $14K | |
| 92225 | 392 | 154 | $13K | |
| 92020 | 104 | 93 | $2K | |
| 92285 | 45 | 41 | $1K | |
| 92002 | 12 | 12 | $690.96 | |
| 76519 | 24 | 12 | $453.10 | |
| 99212 | 13 | 12 | $207.43 | |
| 76514 | 18 | 16 | $140.77 |